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Abstract: Pilomyxoid astrocytomas (P.M.A) are new class of Pilocytic Astrocytoma 
(P.A.) which typically have their origin in hypothalamus and chiasmatic region. There 
are very few case reports of PMAs arising from cerebellum. Their imaging features are 
similar to PA but they behave more aggressively than PA. The authors report a case of 
10 year old male child who presented with right cerebellar tumour diagnosed as PMA on 
histopathology. 
 
Introduction 
Tihan et al, in year 1999, first reported 
PMA as a new variant of pilocytic astrocytoma. 
(1) It has been recently defined as a distinct 
entity among brain tumours and is classified as 
a WHO grade II glial tumour. (2, 3) PMA may 
occur anywhere along the neuraxis but they 
are predominantly present in hypothalamic –
chiasmatic region. (3-5) Very few cases of 
cerebellar PMA are mentioned in literature. 
(6-8) Herein, we report a case of cerebellar 
PMA in a 10 year old male child and discuss 
literature review.    
Case report 
A 10 year old male child presented with 
history of unsteadiness of gait and frequent 
falls for last 3 months. Also, he had developed 
severe headache and vomiting for last 20 days. 
Physical examination revealed grade II 
papilloedema in both eyes with right cerebellar 
signs. 
Imaging: NCCT head revealed a large 
solid-cystic mass in right cerebellum pushing 
the IV ventricle to the opposite side with 
hydrocephalus (Figure 1). The tumour was 
heterogeneously iso to hypo intense on T1WI 
(Figure 2A). DWI revealed anterior cystic and 
posterior solid tumor (Figure 2B). Solid 
portion was hyper intense on T2WI (Figure 
2C) and heterogeneous contrast enhancement 
was seen on gadolinium administration. The 
cyst wall was nonenhancing (Figure 2D). 
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Figure 1 - CT image shows solid cystic lesion in right 
cerebellum with hydrocephalus 
 
 
Figure 2 A - T1WI showing iso to hypointense lesion 
 
 
Figure 2 B - Diffusion weighted image (DWI) 
revealing anterior cystic and posterior solid portion 
 
 
Figure 2 C - Gadolinium enhancement present in 
solid portion 
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Figure 2 D - Non-enhancing cystic portion on 
Gadolinium administration 
 
 
Figure 3 - CT image showing gross total excision of 
tumour 
 
 
Figure 4 - Section shows tumor cells displaying 
monomorphic nuclei with piloid morphology with 
perivascular arrangement of cells with myxiod areas. 
(H&E X200) 
 
 
Figure 5 - IHC GFAP: tumor cells display diffuse 
cytoplasmic expression of GFAP 
 
 
Figure 6 - IHC Ki67: Ki67 expression is low < 1% 
 
  
 
 
 
484          Sharma et al          Cerebellar pilomyxoid astrocytoma 
 
 
 
 
 
 
 
Operation: Patient underwent left sided 
ventriculo peritoneal shunt done to relieve raised 
intracranial pressure and further deterioration. 
After one week,   Right retromastoid suboccipital 
craniectomy was done with gross total excision 
of tumor (Figure 3). Tumour was greyish pink, 
moderately vascular, non suckable mass with 
clear cystic fluid. 
Post operative: The post operative period was 
uneventful. Headache and vomiting were 
relieved immediately after shunt surgery. Child 
was discharged on 8th postoperative day. 
Histopathological examination revealed it 
a case of pilomyxoid astrocytoma. In view of 
this report patient received 40 Gray of 
radiation to whole brain with 14 Gray boost to 
tumour bed. During follow up, his gait 
improved within 2 months. After one year of 
follow up, patient remained asymptomatic 
without any recurrence on contrast CT.  
Histopathology: Haematoxylin and eosin 
stained section displayed a tumor composed of 
piloid cells with monomorphic nuclei. Cells 
were converged near blood vessels in myxoid 
background. Rosenthal fibres and eosinophilic 
bodies were not observed (Figure 4). These 
tumor cells displayed diffuse cytoplasmic 
immunoexpression for Glial Fibrillary Acidic 
Protein (GFAP) (Figure 5) with low Ki-67 
index; less than 1% (Figure 6). Neuronal 
markers like Synaptophysin and neuron- 
specific enolase were negative.        
Discussion  
PMA have been reported in the English 
literature and the overwhelming majority of 
the patients were children aged from 2 months 
to 4 years. (9) PMAs were typically seen in the 
chiasmatic-hypothalamic region, but they 
were also found in other locations, including 
the spinal cord, the temporal lobe, occipital 
lobe and sellar- suprasellar region. (10-12, 19)  
Recent reports have indicated that PMAs can 
occur in adults; a tumor in the 
amygdala/uncus region has been reported in a 
28-year-old man, (13) and a spinal cord PMA 
has been reported in a 45-year-old woman. 
(14)  The case of a 25-year-old man with a 
fourth ventricular PMA has also been 
reported. (15) PMA in cerebellum were 
reported from 2-12 years as in our case whose 
age was 10 years. 
PMA has some specific features in 
histology, which include monomorphous 
growth of piloid cells with an angiocentric 
pattern, being rich in myxoid background, and 
lacking of Rosenthal fibers or eosinophilic 
granular bodies. (16) Similarly, PAs also 
consist of piloid cells, but these cells grow in a 
biphasic pattern, mixed with Rosenthal fibers 
and eosinophilic granular bodies. (16) 
Occurrence of necrosis is more commonly 
associated with PMA, while cyst formation, 
calcification and perilesional edema are more 
common in classic PA. (4) In 
immunohistochemical studies, PMA stains 
strongly positive for glial fibrillary acidic 
protein and vimentin, and is negative for 
neuronal markers. (2) In our case tumor tissue 
was diffusely positive for GFAP and negative 
for neuron-specific enolase. 
On MRI, PMAs also have similar signal 
patterns to PA, and they both show 
isointensity on T1W sequences, 
hyperintensity on T2W sequences and on 
FLAIR images. However, some features could 
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be used to distinguish PMA from PA on MRI. 
PAs are usually cystic with solid mural nodules 
and are surrounded by edema. When contrast 
medium was administered, PA often showed 
intense enhancement in the nodule or the cyst 
wall. On the contrary, PMAs are often solid, 
rarely with peripheral edema. In PMAs, 40% 
cases showed homogenous enhancement and 
30%-60% cases displayed heterogeneous 
enhancement. (4, 17) In our case, the tumor 
showed cyst with a mural nodule. Nodule 
displayed homogenous enhancement while 
cyst wall was non-enhancing. However, 
neuroimaging features cannot yet distinguish 
between PMA and PA, (4) and the diagnosis of 
PMA is made predominantly on the basis of 
distinctive histological features. (2, 4) 
For the patients with PMA, regardless of 
total or partial resection, a majority of the 
postoperative recurrences took place within 
one year and the local recurrence rate was 76%. 
(18) The average survival time was 6 months 
when a recurred tumor was demonstrated by 
MRI. (1, 12) Our patient remained 
asymptomatic without any recurrence on 
contrast CT at one year of follow up. 
Conclusion 
Histopathologist should look for features 
of PMAs whenever they consider the diagnosis 
of PAs as this finding is important for patient 
and surgeon for prognostication and further 
treatment especially in cases of recurrence. 
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